type of glp 1 drugs The ABC's GLP-1s: Benefits, Side Effects, and Success Stories — Nice Healthcare Evolution of GLP‐1 Receptor Agonists

95 Lixisenatide is a short-acting GLP-1RA agent, 96,97 and once-daily lixisenatide can improve patient compliance to a certain extent and reduce the occurrence of hypoglycemia

Cell 185 , 24782494.e2428 (2022)

Both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk (10% and 31%, respectively) as compared with placebo, and an even greater lower risk as compared with DPP-4 inhibitors (15% and 35%, respectively)

and A.D.P

However, they should only be used as a temporary rescue method, not as a daily supplement

GLP-1 is also approved for people without diabetes who are dealing with obesity or weight-related conditions